Bronstein, Gewirtz & Grossman LLC Files Class Action Lawsuit Against PomDoctor, Ltd.

Nationally Recognized Firm Urges PomDoctor Investors to Explore Class Action Representation

Mar. 16, 2026 at 4:21pm

Got story updates? Submit your updates here. ›

Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, has filed a class action lawsuit against PomDoctor, Ltd. (NASDAQ: POM) and certain of its officers. The lawsuit seeks to recover damages for alleged violations of federal securities laws on behalf of all persons and entities that purchased or acquired PomDoctor securities between October 9, 2025 and December 11, 2025.

Why it matters

The lawsuit alleges that PomDoctor was the subject of a fraudulent stock promotion scheme involving social media-based misinformation and impersonated financial professionals, and that insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign. This case highlights the importance of corporate accountability and the need to protect investor capital.

The details

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements and failed to disclose material adverse facts about the company's business, operations, and the true nature of its securities trading activity. Specifically, the Complaint alleges that Defendants failed to disclose to investors: (1) that PomDoctor was the subject of a fraudulent stock promotion scheme; (2) that insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign; (3) that PomDoctor's public statements and risk disclosures omitted any mention of the false rumors and artificial trading activity driving the stock price; and (4) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

  • The Class Period is from October 9, 2025 to December 11, 2025, both dates inclusive.
  • Investors have until April 6, 2026 to request to be appointed as lead plaintiff in the class action lawsuit.

The players

Bronstein, Gewirtz & Grossman, LLC

A nationally recognized investor-rights law firm that represents investors in securities fraud class actions and shareholder derivative suits.

PomDoctor, Ltd.

A company that is the subject of a class action lawsuit alleging a fraudulent stock promotion scheme and other securities law violations.

Got photos? Submit your photos here. ›

What they’re saying

“Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace.”

— Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC

What’s next

A class action lawsuit has already been filed. Investors who purchased or acquired PomDoctor securities between October 9, 2025 and December 11, 2025 have until April 6, 2026 to request to be appointed as lead plaintiff in the class action lawsuit.

The takeaway

This case highlights the importance of corporate accountability and the need to protect investor capital from fraudulent stock promotion schemes and other securities law violations. The class action lawsuit filed by Bronstein, Gewirtz & Grossman, LLC aims to restore investor capital and ensure that PomDoctor is held responsible for its alleged misconduct.